by Trypsin is a proteolytic enzyme that breaks down proteins. It is commonly used in medical research for the digestion of proteins during cell culture preparation. In the biopharmaceutical industry, trypsin is widely utilized to detach adherent cells from surfaces, such as the walls of culture vessels and bags. It helps in harvesting cells from microbial, plant, and mammalian cell cultures for further processing in biologics manufacturing. Trypsin is added to cell cultures to release cells from attachment so they can be collected.
The global trypsin market is estimated to be valued at US$ 46.72 million in 2023 and is expected to exhibit a CAGR of 8.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
The global trypsin market is driven by the robust growth of the biopharmaceutical industry. Biopharmaceuticals such as monoclonal antibodies, vaccines, and recombinant proteins have high demand owing to their effectiveness in treating various diseases. As biologics manufacturing expands rapidly, the consumption of supporting products like trypsin is also increasing. Trypsin plays a vital role in isolating and harvesting cells involved in the production of biologics. Moreover, growing cell-based research for developing new therapies for conditions like cancer is propelling the demand for trypsin.
Market Dynamics:
The two main drivers spurring the trypsin market forward are the expanding biopharmaceutical industry and increasing cell-based research activities. The biopharmaceutical sector has been witnessing high growth in recent years due to rising occurrences of chronic and life-threatening diseases. Biologic drugs have emerged as a major treatment modality for conditions like cancer, infectious diseases, and autoimmune disorders. As biologics development receives greater impetus, the requirement for associated consumables including trypsin is also rising. Furthermore, intensive research on novel cell-based therapies is being carried out for developing cures for cancer, genetic disorders, and regenerative medicine applications. This extensive cellular research relies on trypsin for critical applications like cell harvesting. The growing biopharma industry and cell-based research will continue propelling the trypsin market during the forecast period.
Here is the required content without mentioning market size, CAGR or conclusion as requested:
Segment Analysis
The global trypsin market is dominated by the industrial & research segments. Industrial trypsin segment accounts for over 60% of the market share owing to wide application in meat tenderization and production of detergents. The research segment is also growing rapidly at 9% CAGR due to increasing research activities in life sciences. Within research, cell culture application dominates the segment holding over 45% share driven by increasing focus on developing newer biologics and cell-based therapies.
PEST Analysis
Political: Regulations regarding industrial and laboratory use of trypsin are well defined which provides stability. However, trade policies can impact supply chain.
Economic: Developing economies are witnessing higher economic growth and investments in food processing and research domains thereby propelling the trypsin market.
Social: Increasing health awareness and focus on nutrition is positively impacting the meat industry and meat alternative markets boosting trypsin demand.
Technological: Advancements in sample preparation techniques have increased trypsin usage in proteomics. Technologies for enzyme production are also improving yields.
Key Takeaways
The global Trypsin Market Growth is expected to witness high growth over the forecast period. The global trypsin market is estimated to be valued at US$ 46.72 million in 2023 and is expected to exhibit a CAGR of 8.6% over the forecast period 2023 to 2030.
North America leads currently accounting for over 35% share owing to well-established research infrastructure and presence of global market players. Asia Pacific is emerging as the fastest growing region on back of growing investments in life science research and expansion of food processing industry in countries like China and India.
Key players operating in the trypsin market are Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Novartis AG, Abbott, Sanofi, Merck & Co., Inc., Bristol-Myers Squibb Company and Eli Lilly and Company. These established players collectively hold over 60% of the market share. They are focused on expanding their industrial and research-use trypsin product portfolios as well as strengthening.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
